TGFB1 and cardiac hypertrophy: Selective antagonism of EP2 receptor with AH6809 blocks increased expression of TGF-β1, collagen I and III in both cardiac myocytes and a chronic kidney disease-associated cardiac hypertrophy and fibrosis [20].